Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 75283262 |
Registration Number | 2361023 |
Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
Attorney Name | Michele M. Simkin and Norm J. Rich |
Attorney Docket Number | 029318-1268 |
Law Office Assigned | L50 |
Employee Name | POWERS, ALEXANDER L |
1997-04-29 | Application Filed |
2000-04-04 | Published for Opposition |
2000-06-27 | Trademark Registered |
2010-05-04 | Location: GENERIC WEB UPDATE |
2010-05-04 | Status: Live/Registered |
2010-06-27 | Renewal Date |
2019-06-27 | Transaction Date |
Owner: | ![]() |
Entity Statement | PRIVATE LIMITED COMPANY |
Address | MONKSLAND, ATHLONE CO. WESTMEATH IE |
Legal Entity Type | |
Legal Entity State | IE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | tablet matrix used to improve the solubility and absorption characteristics of poorly water soluble drugs sold as an integral component of various oral pharmaceuticals, namely, antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, cns stimulants, analgesics, antipyretics and anti-infammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, desensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents, for administration to humans |
Description | Date | Event Coding |
---|---|---|
ASSIGNED TO EXAMINER | 1997-11-24 | 1 DOCK D:Assigned to Examiner |
ASSIGNED TO EXAMINER | 1997-11-26 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION MAILED | 1997-11-28 | 3 CNRT F:First Action |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1998-05-28 | 4 CRFA I:Incoming Correspondence |
LETTER OF SUSPENSION MAILED | 1998-06-29 | 5 CNSL F:First Action |
INQUIRY AS TO SUSPENSION MAILED | 1998-12-14 | 6 CNSI O:Outgoing Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-06-11 | 7 CRFA I:Incoming Correspondence |
LETTER OF SUSPENSION MAILED | 1999-07-14 | 8 CNSL F:First Action |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-10-07 | 9 CRFA I:Incoming Correspondence |
INQUIRY AS TO SUSPENSION MAILED | 1999-11-08 | 10 CNSI O:Outgoing Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-11-04 | 11 CRFA I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 1999-12-30 | 12 CNSA O:Outgoing Correspondence |
NOTICE OF PUBLICATION | 2000-03-03 | 13 NPUB O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2000-04-04 | 14 PUBO A:Allowance for Publication |
REGISTERED-PRINCIPAL REGISTER | 2000-06-27 | 15 R.PR A:Allowance for Publication |
CASE FILE IN TICRS | 2006-03-24 | 16 CFIT O:Outgoing Correspondence |
PAPER RECEIVED | 2006-06-26 | 17 MAIL I:Incoming Correspondence |
REVIEW OF CORRESPONDENCE COMPLETE | 2006-10-18 | 18 CORV P: |
CANCELLED SEC. 8 (6-YR) | 2007-03-31 | 19 C8.. O:Outgoing Correspondence |
FAX RECEIVED | 2009-10-16 | 20 FAXX I:Incoming Correspondence |
FAX RECEIVED | 2009-10-23 | 21 FAXX I:Incoming Correspondence |
FAX RECEIVED | 2009-10-23 | 22 FAXX I:Incoming Correspondence |
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | 2006-06-26 | 23 815F I:Incoming Correspondence |
REINSTATED | 2009-11-12 | 24 REIN I:Incoming Correspondence |
FAX RECEIVED | 2009-11-16 | 25 FAXX I:Incoming Correspondence |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2009-11-20 | 26 C15A O:Outgoing Correspondence |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2010-02-03 | 27 ASGN I:Incoming Correspondence |
TEAS SECTION 8 & 9 RECEIVED | 2010-05-03 | 28 E89R I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2010-05-04 | 29 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2010-05-04 | 30 89AG O:Outgoing Correspondence |
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2010-05-04 | 31 RNL1 Q: |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2011-10-05 | 32 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2012-10-17 | 33 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2013-10-16 | 34 ASCK I:Incoming Correspondence |
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2019-06-27 | 35 REM2 E:E-Mail |
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2021-10-29 | 36 CAEX O:Outgoing Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2022-01-26 | 37 ASCK I:Incoming Correspondence |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2022-06-23 | 38 ASCK I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.